Pharmaceuticals, Biotechnology and Life Sciences
CFO Adds Substantial Financial, Medical Technology and Senior Exchange Experience MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”, the “Company”,…
ETCH biotrace to Combine Applied DNA’s DNA tag-based Forensic Traceability and Authenticity with TruTrace’s Industry Blockchain Hub to Deliver Unparalleled…
First engineered, GMP-grade, cryopreserved, off-the-shelf, bi-specific NK cell therapy to enter human clinical trials targeting PD-L1 and CD16 in patients…
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES NEWS WIRE SERVICES HALIFAX, Nova Scotia–(BUSINESS WIRE)–$IMV #AntibioticDeveloper–Biopharmaceutical company…
Veeva delivers a modern cloud application for the management of adverse events PLEASANTON, Calif.–(BUSINESS WIRE)–#drugsafety—Veeva Systems (NYSE:VEEV) today announced the…
Social media and news aggregation site will highlight real-time digital conversations at DIA 2019 DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a…
Additional Data Points to Potential of XERAVA to Treat Carbapenem-Resistant, Multidrug-Resistant Escherichia Coli TP-6076 Demonstrates In Vivo Efficacy…
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY—Bristol-Myers Squibb Company (NYSE:BMY) today announced topline results from CheckMate -459, a randomized Phase 3 study evaluating Opdivo…
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute GvHD with no safety concerns occurring within the study—
Vertex’s third medicine approved to treat the underlying cause of CF in eligible patients in this age range-